関連する実験動画

Updated: Sep 17, 2025

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

36.5K

一発 の インフルエンザ 薬 は ワクチン に 勝る

Jon Cohen

    Science (New York, N.Y.)
    |July 3, 2025
    PubMed
    まとめ

    大規模な研究で,新しい長効インフルエンザ治療薬の1回の注射が,インフルエンザの全シーズンにわたって完全な予防を提供しました. この革新的なワクチンは 季節性インフルエンザの予防を 簡素化して 免疫を延長します

    さらに関連する動画

    Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes08:52

    Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

    Published on: July 26, 2019

    8.2K
    A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies04:47

    A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

    Published on: February 23, 2018

    7.8K

    関連する概念動画

    Vaccinations01:51

    Vaccinations

    Overview
    45.3K
    Cross-reactivity00:42

    Cross-reactivity

    Overview
    31.5K
    Dose-Response Relationship: Potency and Efficacy01:22

    Dose-Response Relationship: Potency and Efficacy

    The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
    5.2K